The HIV care continuum is a representation of the extent to which individuals living with HIV are diagnosed, engaged in care and benefiting from antiretroviral therapy in terms of full viral suppression (undetectable lab values). The value of the continuum in managing the HIV epidemic is compelling: individuals engaged in care can manage HIV as a chronic condition and simultaneously reduce the risk of transmitting the virus to others.
In 2021, the US public was introduced to a bi-monthly injectable form of PrEP, which stands for Pre-Exposure Prophylaxis. Taken in pill form and now also available as an injectable this medication reduces the chance of getting HIV from sex or injection drug use.
We now have more tools than ever available for HIV prevention – a robust toolbox that includes pre-exposure prophylaxis, post-exposure prophylaxis, treatment as prevention, and syringe service programs.
Webinars and other special events by HRSA's HIV/AIDS Bureau.
Preliminary data and lessons learned from the pre-implementation and early-implementation phases of initiatives featured in the DEII project (buprenorphine, women of color, peer support, jail transitional care).
Evidence-informed interventions that produce optimal HIV care outcomes (jail transitional care, buprenorphine, patient navigation and peer support for women of color)
Federal agency that administers the Ryan White HIV/AIDS Program (RWHAP), which helps low-income people with HIV receive care.